Cochleovestibular involvement in patients with Fabry disease: data from the multicenter cohort FFABRY.

Antoine Asquier-KhatiWladimir MauhinGuillaume MichelAdrien GendreCécile DurantChristian LavigneHélène MaillardDidier LacombeMarjolaine WillemsOlivier LidoveAgathe Masseau

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2021)

Hearing loss is particularly frequent in FD and is not limited to classic phenotypes. Close ENT follow-up is essential for Fabry patients to detect those who might benefit from hearing aid. Further studies are needed to define the impact of migalastat on cochleovestibular symptoms.

Keyphrases

hearing loss
end stage renal disease
replacement therapy
newly diagnosed
ejection fraction
prognostic factors
hypertrophic cardiomyopathy
peritoneal dialysis
electronic health record
big data
physical activity
left ventricular
atrial fibrillation
deep learning
double blind
data analysis